HER2 Nanoparticle Safety and Specificity Data Presented at AACR 2019

Marie Zhang, PhD, Vice President of Research and Clinical Development at Imagion Biosystems, presented the poster "HER2 Functionalized Nanoparticles Are Safe…


What's New in Medical Imaging — Radio Interview with Mike Harsh

Click play icon ▶️ to listen (transcript follows below):…


MagSense™ Pre-Clinical Study Presented at 2018 SABCS

On Saturday, December 8, 2018, Marie Zhang, PhD presented the poster "Detection of HER2 Positive Tumor Cells Using Functionalized Iron Oxide Nanoparticles" at…


MagSense™ Technology at ASCO 2018 Annual Meeting

The ASCO 2018 Annual Meeting abstract, "Detection and measurement of HER2+ breast cancer cells using tumor-targeted iron oxide nanoparticles and magnetic…


Pre-clinical Data Presented at the 2017 World Medical Imaging Congress Move MagSense™ Closer to the Clinic

"Specific Detection of HER-2 positive tumors in mice using superparamagnetic relaxometry" is the title of a poster presented by Erika Vreeland, PhD, at the…


Imagion Biosystems at BIO 2017

The 2017 International Convention of BIO, the Biotechnology Innovation Organization, was held June 19-22 in San Diego. More than 16,000 individuals attended…


Tumor Detection Study Presented at "Frontiers in Biomagnetic Particles" Conference

On June 5, 2017, Imagion Biosystems Chief Scientist Erika Vreeland, PhD, presented the results of a collaborative tumor detection study to the scientific…


Pre-IPO Investor Conference Call

On June 20, 2017, Imagion Biosystems President and CEO Bob Proulx provided an update and briefing on the pending Imagion Biosystems initial public offering on…


Magnetic Relaxometry at AACR 2017

This year's Annual Meeting of the American Association for Cancer Research was held April 1-5 in Washington, D.C. The theme of this year's meeting was…


Detecting Cancer Cells with Stealthy Nanoparticles

For effective use in detecting specific types of cancer, tumor-targeting nanoparticles must evade the immune system, remain intact for a clinically relevant…